The clinical and cellular pharmacology of vincristine, corticosteroids, L-asparaginase, anthracyclines and cyclophosphamide in relation to childhood acute lymphoblastic leukaemia.
Estlin
E J
EJ
Department of Paediatric Oncology, Royal Hospital for Sick Children, St Michael's Hill, Bristol BS2 8BJ, UK. e.j.estlin@bristol.ac.uk
Ronghe
M
M
Burke
G A
GA
Yule
S M
SM
D000903:Antibiotics, Antineoplastic / Q000494:pharmacology / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001215:Asparaginase / Q000494:pharmacology / Q000627:therapeutic use; D002477:Cells / Q000187:drug effects; D002648:Child; D003520:Cyclophosphamide / Q000494:pharmacology / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005938:Glucocorticoids / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D012074:Remission Induction; D014750:Vincristine / Q000494:pharmacology / Q000627:therapeutic use
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D005938:Glucocorticoids; D014750:Vincristine; D003520:Cyclophosphamide; D001215:Asparaginase